Hypertension and Nephrology
2017 Hypertension Clinical Guidelines
Nov. 13, 2017 | Hypertension
- This guideline is an update of the National Heart, Lung, and Blood Institute publication, “The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure” (JNC 7) and is a comprehensive resource for the clinical and public health practice communities.
- Previous guidelines identified high blood pressure as ≥ 140/90 mm Hg. This guideline now defines high blood pressure to be anyone with a systolic blood pressure (SBP) ≥ 130 mm Hg or diastolic blood pressure (DBP) ≥ 80 mm Hg.
- The change will mean more patients are diagnosed with hypertension. To improve blood pressure control and reduce cardiovascular disease (CVD) risk in these patients, a small percentage of them will be asked to take medications while the majority will be recommended for nonpharmacological interventions with healthy lifestyle changes.
New 2017 AHA/ACC Hypertension Guidelines
Other Hypertension Guideline Release Resources
- Executive Summary
- Systematic Review
- Hypertension Highlights (PDF)
- Top Ten Things to Know: 2017 Hypertension Clinical Guidelines (PDF)
- Commentary: New hypertension guideline updates how we measure and treat high blood pressure by John Warner, MD, MBA; President, American Heart Association
- Video Series: Clinical Strategies for the 2017 Hypertension Guidelines
- Hypertension Highlights—Detailed Summary (PDF)
- Slide Set: 2017 AHA/ACC Hypertension Clinical Guidelines (PDF)
- AHA News: Nearly half of U.S. adults could now be classified with high blood pressure, under new definitions
- AHA News: Don’t just get your BP taken; make sure it’s taken the right way
- AHA News: Volunteer adds patient’s perspective to new high blood pressure guidelines
- AHA News: More than half of all African-Americans have high blood pressure under new diagnostic guidelines
- News Release: High blood pressure redefined for first time in 14 years: 130 is the new high
Science NewsView All Science News
05/18/2018
05/16/2018 | CIRCULATON Editor's Picks for May 2018
Hypertension Scientific Sessions 2018
Sept. 6-9, 2018
Hyatt Regency Chicago
Chicago, Illinois
Networking for Professionals
Subscribe to AHA's Science News Channel on YouTube for exclusive, late-breaking coverage of over 200 video interviews, panel discussions, welcome messages and more.
Related Councils
Council on Hypertension
The mission of the American Heart Association's Council on Hypertension is to help achieve the association's objectives of "building healthier lives, free of cardiovascular diseases and stroke” by promoting the discovery, translation and dissemination of basic, clinical and population-based research and supporting cutting-edge clinical practice and education on the causes, consequences and treatment of hypertension.
Joey Granger, Ph.D, FAHA
Chair, Council on Hypertension
Council on the Kidney in Cardiovascular Disease (KCVD)
The American Heart Association (AHA) Council on the Kidney in Cardiovascular Disease (KCVD) mission is to reduce cardiovascular-related disability and death through research, communication, advocacy and education about the kidney.
Kidney disease is a major cause and a consequence of cardiovascular disease. Chronic renal insufficiency is thought to be an independent risk factor for developing hypertension, vascular disease, atherosclerosis and other morbidity and mortality risk factors. Patients with cardiovascular disease and diabetes are also at high risk for developing kidney failure.
Núria M. Pastor-Soler, MD, PhD, FASN
Chair, Council on the Kidney in Cardiovascular Disease
Council on Cardiovascular and Stroke Nursing (CVSN)
It is an honor and privilege to serve as Chair of the Council on Cardiovascular and Stroke Nursing (CVSN). I am looking forward to working with all of you to build upon what previous leaders have accomplished.
Nancy T. Artinian, PhD, RN, FAHA, FPCNA, FAAN
Chair, Council on Cardiovascular and Stroke Nursing